Advertisement

Picture EBD Group BioPharm America 2019 Boston September 600x60px

News > All

Total search results: 9799 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 12 13 14 ... 96 97 98  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Life Science Inkubator GmbH. (2/1/18). "Press Release: Life Science Inkubator (LSI) Bonn for the First Time Supports Pharma Industry Spin-out". 2018-02-01
Miltenyi Biotec GmbH. (2/1/18). "Press Release: Cancer Coaching for the Immune System. Novel Cell Therapy Will Teach Immune Cells How to Fight Cancer". Teterow. 2018-02-01
Arnold & Porter LLP. (2/1/18). "Press Release: Announcing Arnold & Porter". 2018-02-01
Affimed N.V.. (2/1/18). "Press Release: Affimed Reports New Data for AFM13 from Two Separate Clinical Trials in Hodgkin and CD30-Positive Lymphomas". Heidelberg. 2018-02-01
Qiagen N.V.. (1/31/18). "Press Release: Qiagen Enters into Agreement to Acquire STAT-Dx, Plans to Launch a Next-generation, Fully Integrated Multiplex Platform for Syndromic Disease Testing". Germantown, MD & Hilden. 2018-01-31
Genedata AG. (1/31/18). "Press Release: Genedata Announces Genedata Screener for Massive Mechanistic Analysis". Basel. 2018-01-31
Analytik Jena AG. (1/31/18). "Press Release: SLAS 2018 — Modular Liquid Handling System CyBio FeliX Automates New Process for Nucleic Acid Extraction". Jena. 2018-01-31
Lonza Group AG. (1/31/18). "Press Release: Lonza Reports Record-breaking Full-year Results with Double-digit Lonza Standalone Sales Growth and More than 26% CORE EBIT Growth in a Major Transformational Year". Basel. 2018-01-31
Sanofi S.A.. (1/31/18). "Press Release: Sanofi, DNDi Seek European Medicines Agency Review for Sleeping Sickness Treatment". Paris & Geneva. 2018-01-31
AiCuris Anti-infective Cures GmbH. (1/31/18). "Press Release: Approval of MSD’s Prevymis (letermovir) by the European Commission Triggers the Next EUR 30 Million Milestone Payment for AiCuris". Wuppertal. 2018-01-31
Oncgnostics GmbH. (1/31/18). "Press Release: Reliable Test for Cervical Cancer Triage Now Available in Slovakia and the Czech Republic". Jena. 2018-01-31
Rentschler Biopharma SE. (1/31/18). "Press Release: Rentschler Biopharma SE Appoints International Biopharma Expert Dr. Ralf Otto as Chief Operating Officer". Laupheim. 2018-01-31
Helsinn Healthcare S.A.. (1/30/18). "Press Release: Helsinn and the Scientific Centre of Monaco Sign Collaboration Agreement". Lugano. 2018-01-30
Creathor Venture Management GmbH. (1/30/18). "Press Release: Creathor Invests in E-Health Platform »Humanoo«". Berlin & Bad Homburg v.d.H.. 2018-01-30
BaseLaunch (BaselArea.swiss). (1/30/18). "Press Release: BaseLaunch up to a Solid Phase II Start". Basel. 2018-01-30
Sanofi S.A.. (1/29/18). "Press Release: Sanofi to Acquire Ablynx for €3.9 Billion". Paris & Ghent. 2018-01-29
Merck KGaA. (1/26/18). "Press Release: Dirk Toepfer Joins Merck as Chief Information Officer". Darmstadt. 2018-01-26
Endress+Hauser AG. (1/26/18). "Press Release: Further Growth for Endress+Hauser in China. Third Plant Inaugurated in Suzhou". 2018-01-26
Novartis AG. (1/26/18). "Press Release: Advanced Accelerator Applications Receives FDA Approval for Lutathera for Treatment of Gastroenteropancreatic Neuroendocrine Tumors". Basel. 2018-01-26
Santhera Pharmaceuticals Holding AG. (1/26/18). "Press Release: Santhera Receives Negative CHMP Opinion on Appeal for Authorization of Raxone in Duchenne Muscular Dystrophy". Liestal. 2018-01-26
Roche. (1/26/18). "Press Release: CHMP Recommends EU Approval of Roche’s Hemlibra for People with Haemophilia A with Inhibitors". Basel. 2018-01-26
Illumina, Inc.. (1/26/18). "Press Release: Illumina Awarded $26.7M in Patent Suit Against Ariosa Diagnostics, Inc.". San Diego, CA. 2018-01-26
ThromboGenics N.V.. (1/26/18). "Press Release: Novartis Pharma AG Holding 5.69% of ThromboGenics Equity Capital". Leuven. 2018-01-26
Clariant. (1/25/18). "Press Release: SABIC Acquires 24.99% Stake in Clariant. SABIC Acquires Stakes Previously Held by 40 North and Corvex Management". Muttenz. 2018-01-25
PerkinElmer, Inc.. (1/25/18). "Press Release: PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year 2017". Waltham, MA. 2018-01-25
Topas Therapeutics GmbH. (1/25/18). "Press Release: Topas Therapeutics Serves as Exclusive Translational Partner for Collaborative Research Center Focused on Liver Inflammation at University Medical Center Hamburg-Eppendorf". Hamburg. 2018-01-25
Novartis AG. (1/24/18). "Press Release: Novartis Delivered Good Operational Performance and Landmark Innovation in 2017, Entering Our Next Growth Phase". Basel. 2018-01-24
Novartis AG. (1/24/18). "Press Release: Novartis exclusively licenses first ophthalmology gene therapy in all markets outside the US, a milestone for patients with rare inherited vision loss". Basel. 2018-01-24
ImmuPharma plc. (1/24/18). "Press Release: Successful Placing to Raise £10 Million". 2018-01-24
Qlucore AB. (1/24/18). "Press Release: Enhanced Collaboration between Qlucore and Nebion to Help Biologists Get More Out of Their Data Analysis". 2018-01-24
CureVac AG. (1/24/18). "Press Release: CureVac Expands Intellectual Property Position that Significantly Improves Protein Expression for its mRNA-Based Vaccines and Therapeutics". Tübingen. 2018-01-24
Genedata AG. (1/24/18). "Press Release: Genedata, HighRes Biosolutions, and Titian Software Collaborate for Automated End-to-End Screening Solution". Basel, Beverly, CA & London. 2018-01-24
Ablynx N.V.. (1/24/18). "Press Release: Ablynx Appoints Dr Robert Friesen as Chief Scientific Officer". Ghent. 2018-01-24
Qiagen N.V.. (1/23/18). "Press Release: Qiagen Receives FDA Clearance for First-ever JAK2 Test for Use in Diagnosis of Additional Myeloproliferative Neoplasms". Hilden & Germantown, MD. 2018-01-23
High-Tech Gründerfonds Management GmbH. (1/23/18). "Press Release: Dräger Invests in HTGF III". 2018-01-23
BCNP Consultants GmbH. (1/22/18). "Press Release: 23rd February Chemistry Industry Innovators from 27 Countries Will Meet at the 2nd European Chemistry Partnering". Frankfurt a. M.. 2018-01-22
Celgene Corporation. (1/22/18). "Press Release: Celgene Corporation to Acquire Juno Therapeutics, Inc., Advancing Global Leadership in Cellular Immunotherapy". Summit, NJ & Seattle, WA. 2018-01-22
Novartis AG. (1/22/18). "Press Release: Novartis Completes Tender Offer for Advanced Accelerator Applications S.A. and Announces Commencement of Subsequent Offering Period". Basel. 2018-01-22
Novartis AG. (1/22/18). "Press Release: Novartis Reports Erenumab Met All Primary and Secondary Endpoints in Unique Phase IIIb Study in Episodic Migraine Patients Who Have Failed Multiple Prior Preventive Treatments". Basel. 2018-01-22
Genmab A/S. (1/22/18). "Press Release: Genmab Announces Novartis' Intention to Transition Arzerra (ofatumumab) from Commercial Availability to Limited Availability via Compassionate Use Programs for the Treatment of CLL in Non-US Markets". Copenhagen. 2018-01-22
Sanofi S.A.. (1/19/18). "Press Release: Sanofi Appoints Dominique Carouge Executive Vice President Head of Business Transformation and Member of the Executive Committee". Paris. 2018-01-19
Biotest AG. (1/19/18). "Press Release: All Conditions Met for Creat Takeover of Biotest". Dreieich. 2018-01-19
Qiagen N.V.. (1/18/18). "Press Release: Qiagen Receives FDA Approval to Expand Use of EGFR Test in Lung Cancer". Germantown, MD & Hilden. 2018-01-18
Inositec AG. (1/18/18). "Press Release: Inositec AG Appoints Dr Frits van Alphen as Chief Medical Officer". Zurich. 2018-01-18
ERS Genomics Ltd.. (1/18/18). "Press Release: ERS Genomics Responds to Revocation of Broad Institute European Patent". Dublin. 2018-01-18
Novartis AG. (1/18/18). "Press Release: Sandoz Announces Exclusive Global Collaboration with Biocon on Next-generation Biosimilars". Holzkirchen. 2018-01-18
Selexis S.A.. (1/17/18). "Press Release: Selexis SA Appoints Alberto Garotti as Chief Financial Officer". Geneva. 2018-01-17
Synpromics Ltd.. (1/17/18). "Press Release: Synpromics Appoints Sarah Haecker Meeks, PhD as Vice President of Business Development. Company Establishes U.S. Subsidiary to Expand Operations". Edinburgh. 2018-01-17
Novartis AG. (1/17/18). "Press Release: Novartis Granted US FDA Priority Review for Kymriah (tisagenlecleucel), formerly CTL019, for Adults with r/r DLBCL". Basel. 2018-01-17
Helmholtz-Zentrum München. (1/17/18). "Press Release: Innovative Antibody Production. Helmholtz Association Funding Spin-off". 2018-01-17
Immatics Biotechnologies GmbH. (1/17/18). "Press Release: Immatics Appoints Thomas Ulmer as Chief Financial Officer". Tübingen & Houston, TX. 2018-01-17
Novartis AG. (1/16/18). "Press Release: Novartis New Data Reinforces Superiority of Cosentyx versus Stelara in Achieving Skin Clearance for Psoriasis Patients". Basel. 2018-01-16
Novartis AG. (1/16/18). "Press Release: Sandoz Regulatory Submission for Proposed Biosimilar Adalimumab Accepted by FDA". Holzkirchen. 2018-01-16
Owkin. (1/16/18). "Press Release: Owkin Closes $11 Million Series A Financing Round". New York, NY. 2018-01-16
Merck KGaA. (1/16/18). "Press Release: Merck Presents Data on Bifunctional Immunotherapy M7824 at ASCO 2018 Gastrointestinal Cancers Symposium". Darmstadt. 2018-01-16
BioNTech Diagnostics GmbH. (1/15/18). "Press Release: BioNTech Announces Results from Two More Studies Demonstrating the Benefits of Breast Cancer Subtyping Using Mammatyper". Mainz. 2018-01-15
Roche. (1/12/18). "Press Release: Roche’s Ocrevus (ocrelizumab) Approved in the European Union for Relapsing Forms of Multiple Sclerosis and Primary Progressive Multiple Sclerosis". Basel. 2018-01-12
Mind the Byte S.L.. (1/11/18). "Press Release: Mind the Byte Acquires Intelligent Pharma". 2018-01-11
Novartis AG. (1/11/18). "Press Release: Novartis Appoints Elizabeth Barrett as Oncology Head". Basel. 2018-01-11
Forty Seven Inc.. (1/11/18). "Press Release: Forty Seven Inc. to Collaborate with Merck KGaA, Darmstadt, Germany, on a Novel Immuno-Oncology Combination for Ovarian Cancer". Menlo Park, CA. 2018-01-11
Forty Seven Inc.. (1/11/18). "Press Release: Forty Seven Inc. to Collaborate on a Novel Immuno-Oncology Combination for Leukemia and Bladder Cancer". Menlo Park, CA. 2018-01-11
Immunic AG. (1/11/18). "Press Release: FDA Approves IND for Immunic Therapeutics’ IMU-838 to Proceed with Phase 2 Study in Ulcerative Colitis". Planegg-Martinsried. 2018-01-11
Gilde Healthcare Partners. (1/11/18). "Press Release: Gilde Healthcare Opens Office in Frankfurt Germany". Utrecht & Frankfurt a. M.. 2018-01-11
Genedata AG. (1/11/18). "Press Release: Genedata Announces New Solution for CRISPR Data Management and Analysis". Basel. 2018-01-11
Sophia Genetics S.A.. (1/11/18). "Press Release: Sophia Genetics Appoints Valentin Matillon as New Chief Financial Officer". St. Sulpice. 2018-01-11
Enamine Ltd.. (1/10/18). "Press Release: Enamine Supplies DSI Poised Fragment and Analogue Libraries to Diamond Light Source XChem Facility and SGC Oxford Screening Efforts". Kiev & Oxford. 2018-01-10
Basilea Pharmaceutica Ltd.. (1/10/18). "Press Release: Basilea Announces Completion of the License Agreement Extension with Pfizer for Antifungal Cresemba for China and Asia Pacific". Basel. 2018-01-10
Scancell Holdings plc. (1/9/18). "Press Release: Scancell to Collaborate with BioNTech to Investigate T cell Receptor based Therapeutics for the Treatment of Cancer". 2018-01-09
Novartis AG. (1/9/18). "Press Release: Novartis Advances Head-to-head Superiority Trials of Cosentyx versus Humira and Proposed Biosimilar Adalimumab". Basel. 2018-01-09
Boehringer Ingelheim. (1/9/18). "Press Release: BeiGene and Boehringer Ingelheim Announce Commercial Supply Agreement for Anti-PD-1 Antibody Tislelizumab". Cambridge, MA, Beijing & China. 2018-01-09
XL-protein GmbH. (1/9/18). "Press Release: Horizon Pharma plc and XL-protein GmbH Have Entered Into a Collaboration Agreement on a Potential Next-Generation Biologic for Uncontrolled Gout Using PASylation® Technology". Freising. 2018-01-09
Genedata AG. (1/9/18). "Press Release: Genedata Screener Raises the Bar on Automation in 2018". Basel. 2018-01-09
MLM Medical Labs GmbH. (1/9/18). "Press Release: New S1 Lab Expands MLM’s Service Portfolio". 2018-01-09
Roche. (1/8/18). "Press Release: Roche and GE Enter Partnership to Develop Integrated Digital Diagnostics Platform to Improve Oncology and Critical Care Treatment". Basel. 2018-01-08
European Invesmtent Bank (EIB). (1/8/18). "Press Release: Investment Plan for Europe. EIB Grants Loan of EUR 40m to Indivumed". 2018-01-08
Evotec AG. (1/8/18). "Press Release: Evotec and Apeiron Achieve First Milestone in Immuno-Oncology Alliance with Sanofi". Hamburg & Vienna. 2018-01-08
Cell Medica Ltd.. (8/1/18). "Press Release: Cell Medica Appoints New CEO to Drive CAR and TCR Clinical Development and Commercialisation". London & Houston, TX. 2018-01-08
Cellestia Biotech AG. (1/4/18). "Press Release: First Patient Dosed in First-in-human Phase l-lla Clinical Study with Cellestia’s Proprietary, Protein-protein Interaction Inhibitor CB-103 Targeting the NOTCH Oncogenic Signalling Pathway in Cancer". Basel 2018-01-04
Oculis S.A.. (1/4/18). "Press Release: Oculis Raises CHF20 Million in a Series B Financing Round to Advance Breakthrough Treatments for Ophthalmic Diseases". Lausanne. 2018-01-04
BioNTech AG. (1/4/18). "Press Release: BioNTech Secures USD 270 Million in Series A Financing". Mainz. 2018-01-04
CureVac AG. (1/4/18). "Press Release: CureVac and Arcturus Therapeutics Announce Broad Strategic Collaboration to Advance Next Generation of Lipid-mediated mRNA Therapeutics". Tübingen, Boston, MA & San Diego, CA. 2018-01-04
Miracor Medical S.A.. (1/4/18). "Press Release: Miracor Medical Raises €25m. Funds Will Be Used to Support Clinical and Prepare Commercial Activities – Company Relocates from Austria to Belgium". Awans & Vienna. 2018-01-04
Enterome S.A.. (1/4/18). "Press Release: Enterome Raises €32 Million ($38.5 Million) in a Series D Financing". Paris & Cambridge, MA. 2018-01-04
Rewind Therapeutics. (1/4/18). "Press Release: Rewind Therapeutics Secures 15.2m Euro to Develop Novel Remyelination Therapies". Leuven. 2018-01-04
Themis Bioscience GmbH. (1/4/18). "Press Release: Themis Raises EUR 10 Million in Series C Financing to Advance Clinical Pipeline". Vienna. 2018-01-04
Roche. (1/4/18). "Press Release: Roche Launches the cobas Plasma Separation Card to Increase Access to HIV testing for Patients Living in Remote Areas". Basel. 2018-01-04
CRISPR Therapeutics AG. (1/4/18). "Press Release: CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares". Zug & Cambridge, MA. 2018-01-04
Biocrates Life Sciences AG. (1/3/18). "Press Release: Biocrates Life Sciences AG Acquires Metanomics Health GmbH to Create a New Global Leader in Metabolomics and Early Disease Detection". Innsbruck. 2018-01-03
Addex Therapeutics S.A.. (1/3/18). "Press Release: Addex and Indivior Sign Strategic Partnership to Accelerate Development of GABAB PAMs as Addiction Treatments". Geneva. 2018-01-03
Boehringer Ingelheim. (1/3/18). "Press Release: Boehringer Ingelheim Demonstrates Continuous Commitment to Its Venture Fund and Fostering Innovation by More than Doubling Funding to 250 M€". Ingelheim & Boston, MA. 2018-01-03
CRISPR Therapeutics AG. (1/3/18). "Press Release: CRISPR Therapeutics Announces Proposed Public Offering of Common Shares". Zug & Cambridge, MA. 2018-01-03
Clariant. (1/2/18). "Press Release: Clariant and Global Bioenergies Unveil Development of New Bio-based Cosmetics Polymer for More Natural Formulations". Muttenz & Evry. 2018-01-02
Bruker Corporation. (12/31/17). "Press Release: Bruker Announces Merger of Japan Subsidiaries". Yokohama. 2017-12-31
Roche. (12/22/17). "Press Release: Roche and Ignyta Reach Definitive Merger Agreement. Roche to Acquire Ignyta for US$ 27.00 per Share". Basel. 2017-12-22
Roche. (12/22/17). "Press Release: Roche Commences Tender Offer for All Shares of Ignyta, Inc. for US$ 27.00 per Share in Cash". Basel. 2017-12-22
Helmholtz-Zentrum München. (12/22/17). "Press Release: Launch of Helmholtz Center Munich’s Stem Cell Center". 2017-12-22
GeNeuro S.A.. (12/21/17). "Press Release: GeNeuro To Receive €12 Million Milestone Payment from Servier for Final Patient Visit in GNbAC1 CHANGE-MS Phase 2b Study". Geneva. 2017-12-21
CRISPR Therapeutics AG. (12/21/17). "Press Release: CRISPR Therapeutics Announces Appointment of Dr. Rodger Novak as Chairman of the Board". Zug & Cambridge, MA. 2017-12-21
Genedata AG. (12/20/17). "Press Release: Genedata Profiler Moves To High-performance Clouds". Basel. 2017-12-20
Merck KGaA. (12/20/17). "Press Release: Merck Signs Commercial Supply Agreement with Bluebird Bio for Viral Vector Manufacturing". Darmstadt. 2017-12-20
next pagenext page 1 2 3 ... 12 13 14 ... 96 97 98  next pagenext page



Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica iito 600x60px

» top